| Literature DB >> 35200247 |
Lauryn Attard1, Victoria Lee1, Jennifer Le1, Chloe Lowe1, Vipra Singh1, Jacky Zhao1, Dileep Sharma1,2.
Abstract
BACKGROUND: To analyze the fracture resistance of zirconia implants within the anterior region and evaluate whether zirconia-zirconia implants can be a viable alternative to titanium implants.Entities:
Keywords: aesthetic zone; dental implant; metal-free; zirconia
Year: 2022 PMID: 35200247 PMCID: PMC8870833 DOI: 10.3390/dj10020022
Source DB: PubMed Journal: Dent J (Basel) ISSN: 2304-6767
Figure 1Flow diagram describing the literature screening and selection process based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [16].
Quality Assessment and Appraisal of Included Studies—Cohort Study.
| Citation | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Roehling et al. (2016) [ | Y | Y | Y | N | N/A | Y | N | Y | Y | N/A | Y |
| Scherrer et al. (2019) [ | N/A | N/A | Y | N/A | N/A | N/A | Y | N/A | N/A | N/A | N/A |
| Percentage (%) | 50 | 50 | 100 | 0 | 0 | 50 | 50 | 50 | 50 | 0 | 50 |
Quality Assessment and Appraisal of Included Studies: Randomized Controlled Trial.
| Citation | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paolantoni et al. (2016) [ | U | N | Y | U | U | U | N | Y | Y | N/A | N/A | Y | U |
| Percentage (%) | 0 | 0 | 100 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 100 | 0 |
Characteristics of Included Studies—Randomized Controlled Trial.
| Study | Country | Setting/Context | Participant Characteristics | Groups | Outcomes Measured | Description of Main Results |
|---|---|---|---|---|---|---|
| Paolantoni et al. 2016 [ | Italy | University of Naples | Patients—65 | Treatment group 1 received standard zirconia anchorage with a layer of lithium disilicate (pressed) and an all-ceramic luted crown (two piece). | Mechanical outcomes: Fracture failure of abutment, restoration and porcelain facing, loss of retention of the abutment due to screw loosening, or restoration fracture. |
Only 2 (out of 45) one-piece restorations fractured. Screw loosening was not reported. None of the implants showed mobility. No significant variations between groups in PI, BI, and MBL at follow-up examination. |
Characteristics of Included Studies—Cohort Studies.
| Study | Country | Setting/Context | Participant Characteristics | Groups | Outcomes Measured | Description of Main Results |
|---|---|---|---|---|---|---|
| Scherrer et al. 2019 [ | Switzerland | Study design: Retrospective Cohort Study. Funding source: Not specified. | Broken first generation monotype zirconia implant parts, upper portion with the crown cemented. | Number of teeth: 15. Axis Biodental Implants (10), Z-Systems Implants (3), Straumann Implants (1), Swiss Dental Solutions Implants (1). | Details of Intervention: Fractographic failure analysis to identify origin of failure and characteristics of surface cracks. |
Transgranular propogation of fracture was noted near the origin. Addition of 0.25 wt% alumina to a 3Y-TZP can increase transgranular fracture due to increased grain–boundary cohesion. Direct relation of fracture origin to large grit alumina sandblasting (Z-System) and porous coating (AXIS Biodental) was evident. Generally, fractures initated from the periphery of the smaller diameter between two threads at the bone level. Occlusal loading to the implant’s central axis can effect bending moments and onset of fracture. |
| Roehling. et al. 2016 [ | Germany | Study design: Retrospective Funding Source: Not specified. | 85 participants (47 female, 38 male) who received a first generation monotype zirconia implant between the dates of Oct 2004 and Nov 2009. Mean age 54.86; 161 implants assessed, 7 smokers (11 implants), 21 patients had bruxism (57 implants). | Only 1 group measured at initial placement and at/near 7 years. | Details of intervention: Data collected-number, diameter, length and position of implants, age, gender, risk factors, and bone quality and intra-oral image. |
125 implants survived; 36 implants lost early. Mean values noted: GI-0.03; PI-0.23; mBI-0.59; PD-2.8 mm. Radiographically mean crestal bone loss was 0.97 ± 0.07 mm and diameter-reduced implants showed lower survival rate (3.25 mm = 58.5% survival, 4 mm = 89.9%, 5 mm = 78.6%). Satisfaction with esthetical outcome of zirconia implant after 7 years-90%. 18 of the 36 failed implants were due to fracture at the sandblasted portion of the coronal part of the implant. Highest survival rate was noted for implant placement at 40–59 years of age. |
Databases searched, and MeSH terms used.
| Database | MeSH Terms and Search Strategy |
|---|---|
| Scopus | (“fract* resistan*” OR “fract* analys*” OR “fract* behavio*r” OR “fract* strength” OR fract* OR “fract* dimension” OR “fract* tough*” OR “fract* model” OR fragment* OR break* OR crack* OR fissure* OR split*) AND (“two-piece zirconia” OR “two piece zirconia” OR “2 piece zirconia” OR “2-piece zirconia” OR “zirconia implant*” OR “zirconia screw” OR “zirconia abutment*”) AND TITLE-ABS-KEY (anterior OR “anterior area” OR “anterior zone” OR “anterior section” OR “anterior region” OR “anterior segment” OR maxil* OR “*esthetic zone” OR “*esthetic region” OR “*esthetic area” OR “*esthetic section” OR “*esthetic segment”) AND TITLE-ABS-KEY (implant* OR abut*)) |
| Ovid |
fract* resistan*.mp. fract* analys*.mp. fract* behavio*r.mp. fract* strength.mp. fract*.mp. fract* dimension.mp. fract* tough*.mp. fract* model.mp. fragment*.mp. break*.mp. crack*.mp. fissure*.mp. split*.mp. two-piece zirconia.mp. two piece zirconia.mp. 2 piece zirconia.mp. 2-piece zirconia.mp. zirconia implant*.mp. zirconia screw.mp. zirconia abutment*.mp. anterior.mp. anterior area.mp. anterior zone.mp. anterior section.mp. anterior region.mp. anterior segment.mp. maxil*.mp. esthetic zone.mp. aesthetic zone.mp. esthetic region.mp. aesthetic region.mp. esthetic area.mp. aesthetic area.mp. esthetic section.mp. aesthetic section.mp. esthetic segment.mp. aesthetic segment.mp. implant*.mp. abut*.mp. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 14 or 15 or 16 or 17 or 18 or 19 or 20 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 38 or 39 40 and 41 and 42 and 43 |
| PubMed | (maxilla OR maxil* OR anterior OR “anterior area” OR “anterior region” OR “anterior zone” OR “anterior section” OR “aesthetic zone” OR “aesthetic area” OR “esthetic zone” OR “esthetic area”) AND (fract* OR “fracture resistance” OR “fractal behaviour” OR “fracture behaviour” OR “fracture strength” OR “fractal dimension” OR “fracture toughness” OR “fracture model” OR “fractal model” OR break* OR crack* OR fissure* OR split*) AND (“two piece zirconia” OR “two-piece zirconia” OR “2-piece zirconia” OR “2 piece zirconia” OR “zirconia abutment” OR “zirconia implant” OR zirconia implants”) |
| Cochrane Library | (“fract* resistan*” OR “fract* analysis” OR fracture OR fractures OR “fract* behaviour” OR “fracture strength” OR “fract* dimension” OR “fractal toughness” OR “fracture toughness” OR “fractal model” OR “fracture model” OR fragment* OR break* OR crack* OR fissure* OR split*) AND (“two-piece zirconia” OR “two piece zirconia” OR “2 piece zirconia” OR “2-piece zirconia” OR “zirconia abutment*” OR “zirconia screw” OR “zirconia implant*”) AND (anterior OR “anterior area” OR “anterior zone” OR “anterior section” OR “anterior region” OR “anterior segment” OR maxil* OR “aesthetic zone” OR “esthetic zone” OR “aesthetic region” OR “*esthetic region” OR “aesthetic area” OR “*esthetic area” OR “aesthetic section” OR “*esthetic section” OR “aesthetic segment” OR “*esthetic segment”) |
Jbi Sumari Appraisal Tools [23].
|
| |||||
|
|
|
|
|
| |
| 1 | Was true randomization used for assignment of participants to treatment groups? | ||||
| 2 | Was allocation to treatment groups concealed? | ||||
| 3 | Were treatment groups similar at the baseline? | ||||
| 4 | Were participants blind to treatment assignment? | ||||
| 5 | Were those delivering treatment blind to treatment assignment? | ||||
| 6 | Were outcomes assessors blind to treatment assignment? | ||||
| 7 | Were treatment groups treated identically other than the intervention of interest? | ||||
| 8 | Was follow-up complete and if not, were differences between groups in terms of their follow-up adequately described and analyzed? | ||||
| 9 | Were participants analyzed in the groups to which they were randomized? | ||||
| 10 | Were outcomes measured in the same way for treatment groups? | ||||
| 11 | Were outcomes measured in a reliable way? | ||||
| 12 | Was appropriate statistical analysis used? | ||||
| 13 | Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial? | ||||
| Overall appraisal: | |||||
|
| |||||
|
|
|
|
|
| |
| 1 | Were the two groups similar and recruited from the same population? | ||||
| 2 | Were the exposures measured similarly to assign people to both exposed and unexposed groups? | ||||
| 3 | Was the exposure measured in a valid and reliable way? | ||||
| 4 | Were confounding factors identified? | ||||
| 5 | Were strategies to deal with confounding factors stated? | ||||
| 6 | Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? | ||||
| 7 | Were the outcomes measured in a valid and reliable way? | ||||
| 8 | Was the follow-up time reported and sufficient to be long enough for outcomes to occur? | ||||
| 9 | Was follow-up complete, and if not, were the reasons for lack of follow-up described and explored? | ||||
| 10 | Were strategies to address incomplete follow-up utilized? | ||||
| 11 | Was appropriate statistical analysis used? | ||||
| Overall appraisal: | |||||